Sustained expression of Homeobox D10 inhibits angiogenesis

American Journal of Pathology

Volumn 161, Issue 6, 2002, Pages 2099-2109

  Myers, Connie ^a   Charboneau, Aubri ^a   Cheung, Irene ^a   Hanks, Douglas ^b   Boudreau, Nancy ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HOMEODOMAIN PROTEIN; HOMEODOMAIN PROTEIN D10; MESSENGER RNA; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036899023     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64488-4     Document Type: Article

References (40)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
2. Conway EM, Collen D, Carmeliet P: Molecular mechanisms of blood vessel growth Cardiovasc Res 2001, 49:507-521
3. Brooks PC, Montgomery AMP, Rosenfeld M, Riesfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79: 1157-1164
4. Eliceiri BP, Cheresh DA: The role of alpha v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J Clin Invest 1999, 103:1227-1230
5. Werb Z, Vu TH, Rinkenberger JL, Coussens LM: Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 1999, 107:11-18
6. Botas J: Control of morphogenesis and differentiation by HOM/Hox genes. Curr Opin Cell Biol 1993, 5:1015-1022
7. Edelman GM, Jones FS: Outside and downstream of the homeobox. J Biol Chem 1993, 268:20683-20686
8. Boudreau N, Bissell MJ: Extracellular matrix signaling: Integration of form and function in normal and malignant cells. Curr Opin Cell Biol 1998, 10:640-646
9. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA: Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997, 139:257-264
10. Belotti D, Clausse N, Flagiello D, Alami Y, Daukandt M, Deroanne C, Malfoy B, Boncinelli E, Faiella A, Castronovo V: Expression and modulation of homeobox genes from cluster B in endothelial cells. Lab Invest 1998, 78:1291-1299
11. Patel CV, Sharangpani R, Bandyopadhyay S, DiCorleto PE: Endothelial cells express a novel, tumor necrosis factor-alpha-regulated variant of HOXA9. J Biol Chem 1999, 274:1415-1422
12. Myers CA, Charboneau A, Boudreau N: Hox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 2000, 148:343-352
13. Duboule D: Vertebrate hox gene regulation: Clustering and/or colinearity? Curr Opin Genet Dev 1998, 8:514-518
14. Van Oostveen JW, Bijl JJ, Walboomers JLM, Meijer CJLM: The role of homeobox genes in normal hematopoiesis and hematological malignancies. Leukemia 1999, 13:1675-1690
15. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Humphries RK: Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994, 91:12223-12227
16. Bromleigh VC, Freedman LP: p21 is a transcriptional target of HoxA10 in differentiating myelomonocytic cells. Genes Dev 2000, 14:2581-2586
17. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690
18. Xu Y, Swerlick RA, Sepp N, Bosse D, Ades EA, Lawley TJ: Characterization of expression and modulation of cell adhesion molecules on an immortalized dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 1994, 102:833-837
19. Nehls V, Drenckhahn D: A novel microcarrier-based in vitro assay for rapid and quantification of three-dimensional cell migration and angiogenesis. Microvasc Res 1995, 50:311-322
20. Uyeno LA, Newman J, Cheung I, Hunt TK, Young DM, Boudreau N: HoxD3 expression in normal and impaired wound healing. J Surg Res 2001, 100:46-56
21. Nor JE, Peters MC, Christensen JB, Sutorik MM, Linn S, Khan MK, Addison CL, Mooney DJ, Polverini PJ: Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 2001, 81:453-463
22. Engels K, Fox SB, Whitehouse RM, Gatter KC, Harris AL: Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast. J Pathol 1997, 181:207-212
23. Guidi AJ, Schnitt SJ, Fische RL, Tognazzi K, Harris JR, Dvorak HF, Brown LF: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 1997, 80:1945-1953
24. Kroon ME, Koolwijk P, van Goor H, Wiedle UH, Collen A, van der Plijm G, van Hinsbergh VWM: Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol 1999, 154:1731-1742
25. Ellerbrook SM, Stack SM: Membrane associated matrix metalloproteinases in metastasis. Bioessays 1999, 21:940-949
26. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ: Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998, 95:365-377
27. Kubota Y, Kleinman HK, Martin GR, Lawley TJ: Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1988, 107: 1589-1596
28. Shaw LM, Rabinovitz I, Wang HH, Toker A, Mercurio AM: Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 1997, 91:949-960
29. Gianelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V: Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science 1997, 277:225-228
30. Muschler J, Lochter A, Roskelley CD, Yurchenco P, Bissell MJ: Division of labor among the a6β4 integrin, β1 integrins and an E3 laminin receptor to signal morphogenesis and β casein expression in mammary epithelial cells. Mol Biol Cell 1999, 10:2817-2828
31. Clark EA, Golub TR, Lande RES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406:532-535
32. Howlett AR, Petersen OW, Steeg PS, Bissell MJ: A novel function for the nm-23H1 gene: Overexpression in human breast carcinoma cells leads to the formation of basement membranes and growth arrest. J Natl Cancer Inst 1994, 86:1838-1844
33. Osborne J, Hu C, Hawley C, Underwood LJ, O'Brien TJ, Baker VV: Expression of HOXD10 gene in normal endometrium and endometrial adenocarcinoma. Soc Gynecol Invest 1998, 5:277-280
34. DuBoule D: The Guidebook to the Homeobox Genes. Edited by Sambrook, Tooze. New York, Oxford Press, 1994
35. Duboule D, Morata G: Colinearity and functional heirarchy among genes of the homeotic complexes. Trends Genet 1994, 10:358-364
36. Azpiazu N, Morata G: Functional and regulatory interactions between Hox and extradenticle genes. Genes Dev 1998, 12:261-273
37. Shen W-F, Rozenfeld S, Lawrence HJ, Largman C: The Abd-B Hox homeodomain proteins can be subdivided by the ability to form complexes with Pbxla on a novel DNA target. J Biol Chem 1997, 272:8198-8206
38. Gould AP, Brookman JJ, Strutt DI, White RAH: Targets of homeotic gene control in Drosophila Nature 1990, 348:308-311
39. Johnson A: Transcriptional Regulation. Edited by SL McKnight, KR Yamamoto. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1992, pp 975-1006
40. Capovilla M, Botas J: Functional dominance among Hox genes: Repression dominates activation in the regulation of Dpp. Development 1998, 125:4949-4957